2 results
Approved WMOCompleted
In this study we want to determine the activity and safety of concurrent interruption of the MAPK and PI3K pathways by the EGFR tyrosine kinase inhibitor erlotinb and metformin, combined with gemcitabine in patients with metatastatic pancreatic…
Approved WMOPending
OBJECTIVESPrimary Objective• To assess the efficacy of efzofitimod in patients with pulmonary sarcoidosis Secondary Objectives• To assess the safety and tolerability of efzofitimod in patients with pulmonary sarcoidosisExploratory Objectives• To…